Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients

Prof Wolfgang Janni - Ulm University, Ulm, Germany
Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients ( Prof Wolfgang Janni - Ulm University, Ulm, Germany )
11 Dec 2020

ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with phosphoethanolamine

Dr Diletta Fontana - The University of Milano-Bicocca, Milan, Italy
ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with phosphoethanolamine ( Dr Diletta Fontana - The University of Milano-Bicocca, Milan, Italy )
11 Dec 2020

Latest data for managing ALK NSCLC patients

Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea
Latest data for managing ALK  NSCLC patients ( Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea )
11 Dec 2020

Pregnancy outcomes in breast cancer survivors; meta-analysis

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Pregnancy outcomes in breast cancer survivors; meta-analysis ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
10 Dec 2020

ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM

Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA
ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM ( Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA )
9 Dec 2020

Peripheral blood CD26 leukaemia stem cell monitoring in CML during TKI treatment

Prof Monica Bocchia - University of Siena, Siena, Italy
Peripheral blood CD26 leukaemia stem cell monitoring in CML during TKI treatment ( Prof Monica Bocchia - University of Siena, Siena, Italy )
8 Dec 2020

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings

Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA
Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings ( Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA )
8 Dec 2020

Treating acute leukaemias of ambiguous lineage

Dr Lindsey Montefiori - Department of Pathology, St. Jude Children's Research Hospital, USA
Treating acute leukaemias of ambiguous lineage ( Dr Lindsey Montefiori - Department of Pathology, St. Jude Children's Research Hospital, USA )
8 Dec 2020

First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation

Dr Jorge Cortes - Augusta University, Augusta, USA
First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation ( Dr Jorge Cortes - Augusta University, Augusta, USA )
8 Dec 2020

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA
Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )
8 Dec 2020

Analysis of the B-HOLISTIC study and importance of relapsed/refractory Hodgkin lymphoma real world evidence data

Prof Mark Hertzberg - Prince of Wales Hospital, Sydney, Australia
Analysis of the B-HOLISTIC study and importance of relapsed/refractory Hodgkin lymphoma real world evidence data ( Prof Mark Hertzberg - Prince of Wales Hospital, Sydney, Australia )
8 Dec 2020

Five year update of ECHELON-1 for classical Hodgkin lymphoma

Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil
Five year update of ECHELON-1 for classical Hodgkin lymphoma ( Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil )
8 Dec 2020